TOKYO -- The approval of Avigan, a candidate drug for treating coronavirus infections, has been postponed by Japan's Ministry of Health, Labor and Welfare until June or later.
Pharmaceuticals
Avigan still awaits Japanese approval as coronavirus cure
Optimism shrinks as clinical trials fail to produce definitive results
Proof of Avigan's effectiveness in curing COVID-19 patients remains out of reach. (generic name : Favipiravir). © Reuters
Read Next
Latest on Pharmaceuticals
